In a study, the authors injected HK2 inhibitor, 3-bromopyruvate (BrPA), into mice with arthritis models, which inhibited glycolysis levels and resulted in a significant decrease in arthritis levels (9). This evidence concerns the gene HK2 and arthritic joint disease.